Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of INTEL CORP from Q4 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Intel Corp quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q4 2016 to Q1 2025.
  • Intel Corp Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 29 Mar 2025 was $8.95B, a 29.2% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

INTEL CORP Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $8.95B +$2.02B +29.2% 29 Mar 2025 10-Q 25 Apr 2025
Q4 2024 $8.25B +$1.17B +16.5% 28 Dec 2024 10-Q 25 Apr 2025
Q3 2024 $8.79B +$1.16B +15.3% 28 Sep 2024 10-Q 01 Nov 2024
Q2 2024 $11.3B +$2.94B +35.2% 29 Jun 2024 10-Q 02 Aug 2024
Q1 2024 $6.92B -$1.31B -15.9% 30 Mar 2024 10-Q 25 Apr 2025
Q4 2023 $7.08B -$4.07B -36.5% 30 Dec 2023 10-Q 25 Apr 2025
Q3 2023 $7.62B +$3.09B +68.3% 30 Sep 2023 10-Q 01 Nov 2024
Q2 2023 $8.35B +$3.96B +90.2% 01 Jul 2023 10-Q 02 Aug 2024
Q1 2023 $8.23B +$2.02B +32.5% 01 Apr 2023 10-Q 26 Apr 2024
Q4 2022 $11.1B +$6.32B +131% 31 Dec 2022 10-K 31 Jan 2025
Q3 2022 $4.53B -$3.34B -42.5% 01 Oct 2022 10-Q 27 Oct 2023
Q2 2022 $4.39B -$356M -7.5% 02 Jul 2022 10-Q 28 Jul 2023
Q1 2022 $6.22B +$1.02B +19.7% 02 Apr 2022 10-Q 28 Apr 2023
Q4 2021 $4.83B -$1.04B -17.7% 25 Dec 2021 10-K 31 Jan 2025
Q3 2021 $7.87B 25 Sep 2021 10-Q 28 Oct 2022
Q2 2021 $4.75B 26 Jun 2021 10-Q 29 Jul 2022
Q1 2021 $5.19B 27 Mar 2021 10-Q 29 Apr 2022
Q4 2020 $5.87B +$1.67B +39.8% 26 Dec 2020 10-K 26 Jan 2024
Q4 2019 $4.19B +$1.18B +38.9% 28 Dec 2019 10-K 27 Jan 2023
Q4 2018 $3.02B -$414M -12.1% 29 Dec 2018 10-K 27 Jan 2022
Q4 2017 $3.43B -$2.13B -38.3% 30 Dec 2017 10-K 22 Jan 2021
Q4 2016 $5.56B 31 Dec 2016 10-K 24 Jan 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.